Tokyo Tape
Sign in
← Manac Chemical Partners

Annual report

4360.TEDINET S100R3ZN
Period2022-04-01 → 2023-03-31
Filed2023-06-30
StandardJapan GAAP
ConsolidatedYes
Data checks22 of 22 passed
Key figures · 72
MetricValuePeriodScopeSource row
Revenue¥11.9bn2022-04-01 → 2023-03-31Cons.Net sales
Revenue¥10.7bn2021-04-01 → 2022-03-31Cons.Net sales
Operating income¥991m2022-04-01 → 2023-03-31Cons.Operating income
Operating income¥740m2021-04-01 → 2022-03-31Cons.Operating income
Ordinary income¥1.2bn2022-04-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥881m2021-04-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥1.1bn2022-04-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥940m2021-04-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥821m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥712m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥821m2022-04-01 → 2023-03-31Cons.Profit loss
Net income¥712m2021-04-01 → 2022-03-31Cons.Profit loss
Total assets¥15.0bnat 2023-03-31Cons.Assets
Total assets¥13.6bnat 2022-03-31Cons.Assets
Total liabilities¥4.0bnat 2023-03-31Cons.Liabilities
Total liabilities¥3.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥11.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥10.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥9.8bnat 2021-03-31dCons.Net assets
Cash and deposits¥3.7bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥2.0bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥3.7bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.0bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥714m2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Investing cash flow¥199m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥422m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥125m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥200m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥103.262022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.522021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
Net assets per share¥1,384.71at 2023-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥1,300.81at 2022-03-31Cons.Net assets per share (5-year summary)
Equity ratio73.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio75.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
ROE7.7%2022-04-01 → 2023-03-31Cons.Rate of return on equity (5-year summary)
ROE6.9%2021-04-01 → 2022-03-31Cons.Rate of return on equity (5-year summary)
Employees236at 2023-03-31Cons.Number of employees
Employees241at 2022-03-31Cons.Number of employees
Revenue¥672m2022-04-01 → 2023-03-31StandaloneOperating revenue1
Revenue¥317m2021-04-01 → 2022-03-31StandaloneOperating revenue1
Operating income¥375m2022-04-01 → 2023-03-31StandaloneOperating income
Operating income¥173m2021-04-01 → 2022-03-31StandaloneOperating income
Ordinary income¥760m2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥188m2021-04-01 → 2022-03-31StandaloneOrdinary income
Profit before tax¥814m2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Profit before tax¥242m2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Net income¥662m2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥174m2021-04-01 → 2022-03-31StandaloneProfit loss
Total assets¥11.2bnat 2023-03-31StandaloneAssets
Total assets¥10.6bnat 2022-03-31StandaloneAssets
Total liabilities¥165mat 2023-03-31StandaloneLiabilities
Total liabilities¥79mat 2022-03-31StandaloneLiabilities
Net assets / equity¥11.1bnat 2023-03-31StandaloneNet assets
Net assets / equity¥10.5bnat 2022-03-31StandaloneNet assets
Cash and deposits¥1.5bnat 2023-03-31StandaloneCash and deposits
Cash and deposits¥700mat 2022-03-31StandaloneCash and deposits
EPS (basic)¥83.292022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥22.052021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥152022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥7.52021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Net assets per share¥1,388.88at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,324.77at 2022-03-31StandaloneNet assets per share (5-year summary)
Equity ratio98.5%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio99.2%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
ROE6.1%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE1.7%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
Shares issued8,625,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued8,625,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Employees8at 2023-03-31StandaloneNumber of employees
Employees7at 2022-03-31StandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 60
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2022-04-01 → 2023-03-31¥91m
Reconciling Itemsreconcilingdepreciation2022-04-01 → 2023-03-31¥117m
Reconciling Itemsreconcilingsegment assetsat 2023-03-31¥6.1bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2023-03-31−¥1.1bn
Fine Chemical Businessreportable segmentcapex2022-04-01 → 2023-03-31¥62m
Fine Chemical Businessreportable segmentdepreciation2022-04-01 → 2023-03-31¥218m
Fine Chemical Businessreportable segmentemployeesat 2023-03-3196 pure
Fine Chemical Businessreportable segmentrevenue2022-04-01 → 2023-03-31¥4.3bn
Fine Chemical Businessreportable segmentrevenue external2022-04-01 → 2023-03-31¥4.3bn
Fine Chemical Businessreportable segmentsegment assetsat 2023-03-31¥4.9bn
Fine Chemical Businessreportable segmentsegment profit2022-04-01 → 2023-03-31¥768m
Flame Retardants Businessreportable segmentcapex2022-04-01 → 2023-03-31¥101m
Flame Retardants Businessreportable segmentdepreciation2022-04-01 → 2023-03-31¥120m
Flame Retardants Businessreportable segmentemployeesat 2023-03-3147 pure
Flame Retardants Businessreportable segmentrevenue2022-04-01 → 2023-03-31¥6.2bn
Flame Retardants Businessreportable segmentrevenue external2022-04-01 → 2023-03-31¥6.2bn
Flame Retardants Businessreportable segmentsegment assetsat 2023-03-31¥3.1bn
Flame Retardants Businessreportable segmentsegment profit2022-04-01 → 2023-03-31¥1.3bn
Health Support Businessreportable segmentcapex2022-04-01 → 2023-03-31¥31m
Health Support Businessreportable segmentdepreciation2022-04-01 → 2023-03-31¥31m
Health Support Businessreportable segmentemployeesat 2023-03-3114 pure
Health Support Businessreportable segmentrevenue2022-04-01 → 2023-03-31¥1.3bn
Health Support Businessreportable segmentrevenue external2022-04-01 → 2023-03-31¥1.3bn
Health Support Businessreportable segmentsegment assetsat 2023-03-31¥845m
Health Support Businessreportable segmentsegment profit2022-04-01 → 2023-03-31¥31m
—segment totalcapex2022-04-01 → 2023-03-31¥195m
—segment totaldepreciation2022-04-01 → 2023-03-31¥369m
—segment totalemployeesat 2023-03-31157 pure
—segment totalrevenue2022-04-01 → 2023-03-31¥11.9bn
—segment totalrevenue external2022-04-01 → 2023-03-31¥11.9bn
—segment totalsegment assetsat 2023-03-31¥8.9bn
—segment totalsegment profit2022-04-01 → 2023-03-31¥2.1bn
Reconciling Itemsreconcilingcapex2021-04-01 → 2022-03-31¥70m
Reconciling Itemsreconcilingdepreciation2021-04-01 → 2022-03-31¥107m
Reconciling Itemsreconcilingsegment assetsat 2022-03-31¥4.9bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2022-03-31−¥1.0bn
Fine Chemical Businessreportable segmentcapex2021-04-01 → 2022-03-31¥316m
Fine Chemical Businessreportable segmentdepreciation2021-04-01 → 2022-03-31¥200m
Fine Chemical Businessreportable segmentrevenue2021-04-01 → 2022-03-31¥4.5bn
Fine Chemical Businessreportable segmentrevenue external2021-04-01 → 2022-03-31¥4.5bn
Fine Chemical Businessreportable segmentsegment assetsat 2022-03-31¥5.0bn
Fine Chemical Businessreportable segmentsegment profit2021-04-01 → 2022-03-31¥637m
Flame Retardants Businessreportable segmentcapex2021-04-01 → 2022-03-31¥196m
Flame Retardants Businessreportable segmentdepreciation2021-04-01 → 2022-03-31¥113m
Flame Retardants Businessreportable segmentrevenue2021-04-01 → 2022-03-31¥5.0bn
Flame Retardants Businessreportable segmentrevenue external2021-04-01 → 2022-03-31¥5.0bn
Flame Retardants Businessreportable segmentsegment assetsat 2022-03-31¥2.9bn
Flame Retardants Businessreportable segmentsegment profit2021-04-01 → 2022-03-31¥993m
Health Support Businessreportable segmentcapex2021-04-01 → 2022-03-31¥80m
Health Support Businessreportable segmentdepreciation2021-04-01 → 2022-03-31¥29m
Health Support Businessreportable segmentrevenue2021-04-01 → 2022-03-31¥1.2bn
Health Support Businessreportable segmentrevenue external2021-04-01 → 2022-03-31¥1.2bn
Health Support Businessreportable segmentsegment assetsat 2022-03-31¥773m
Health Support Businessreportable segmentsegment profit2021-04-01 → 2022-03-31¥158m
—segment totalcapex2021-04-01 → 2022-03-31¥593m
—segment totaldepreciation2021-04-01 → 2022-03-31¥343m
—segment totalrevenue2021-04-01 → 2022-03-31¥10.7bn
—segment totalrevenue external2021-04-01 → 2022-03-31¥10.7bn
—segment totalsegment assetsat 2022-03-31¥8.6bn
—segment totalsegment profit2021-04-01 → 2022-03-31¥1.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,263
ItemContextValueUnit
Net cash provided by used in investing activities (5-year summary)CurrentYearDuration199000000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration-200000000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYearDuration-125000000JPY
Cash and cash equivalents (5-year summary)Prior1YearInstant2039000000JPY
Cash and cash equivalents (5-year summary)CurrentYearInstant3721000000JPY
Number of employeesPrior1YearInstant241
Number of employeesCurrentYearInstant236
Operating revenue1 (5-year summary)Prior1YearDuration_NonConsolidatedMember317000000JPY
Operating revenue1 (5-year summary)CurrentYearDuration_NonConsolidatedMember672000000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember188000000JPY
Ordinary income loss (5-year summary)CurrentYearDuration_NonConsolidatedMember760000000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember174000000JPY
Net income loss (5-year summary)CurrentYearDuration_NonConsolidatedMember662000000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember300000000JPY
Capital stock (5-year summary)CurrentYearInstant_NonConsolidatedMember300000000JPY
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember8625000
Total number of issued shares (5-year summary)CurrentYearInstant_NonConsolidatedMember8625000
Net assets (5-year summary)Prior1YearInstant_NonConsolidatedMember10483000000JPY
Net assets (5-year summary)CurrentYearInstant_NonConsolidatedMember11072000000JPY
Total assets (5-year summary)Prior1YearInstant_NonConsolidatedMember10563000000JPY
Total assets (5-year summary)CurrentYearInstant_NonConsolidatedMember11238000000JPY
Net assets per share (5-year summary)Prior1YearInstant_NonConsolidatedMember1324.77
Net assets per share (5-year summary)CurrentYearInstant_NonConsolidatedMember1388.88
Dividend paid per share (5-year summary)Prior1YearDuration_NonConsolidatedMember7.5
Dividend paid per share (5-year summary)CurrentYearDuration_NonConsolidatedMember15.0
Interim dividend paid per share (5-year summary)Prior1YearDuration_NonConsolidatedMember－
Interim dividend paid per share (5-year summary)CurrentYearDuration_NonConsolidatedMember7.5
Basic earnings loss per share (5-year summary)Prior1YearDuration_NonConsolidatedMember22.05
Basic earnings loss per share (5-year summary)CurrentYearDuration_NonConsolidatedMember83.29
Diluted earnings per share (5-year summary)Prior1YearDuration_NonConsolidatedMember－
Diluted earnings per share (5-year summary)CurrentYearDuration_NonConsolidatedMember－
Equity to asset ratio (5-year summary)Prior1YearInstant_NonConsolidatedMember0.992
Equity to asset ratio (5-year summary)CurrentYearInstant_NonConsolidatedMember0.985
Rate of return on equity (5-year summary)Prior1YearDuration_NonConsolidatedMember0.017
Rate of return on equity (5-year summary)CurrentYearDuration_NonConsolidatedMember0.061
Price earnings ratio (5-year summary)Prior1YearDuration_NonConsolidatedMember24.0
Price earnings ratio (5-year summary)CurrentYearDuration_NonConsolidatedMember9.6
Payout ratio (5-year summary)Prior1YearDuration_NonConsolidatedMember0.340
Payout ratio (5-year summary)CurrentYearDuration_NonConsolidatedMember0.180
Number of employeesPrior1YearInstant_NonConsolidatedMember7
Number of employeesCurrentYearInstant_NonConsolidatedMember8
Total shareholder returnPrior1YearInstant_NonConsolidatedMember1.028
Total shareholder returnCurrentYearInstant_NonConsolidatedMember1.575
Total return on share price indexPrior1YearInstant_NonConsolidatedMember1.246
Total return on share price indexCurrentYearInstant_NonConsolidatedMember1.318
Number of employeesCurrentYearInstant_jpcrp030000-asr_E36769-000FineChemicalBusinessReportableSegmentsMember96
Number of employeesCurrentYearInstant_jpcrp030000-asr_E36769-000FlameRetardantsBusinessReportableSegmentsMember47
Number of employeesCurrentYearInstant_jpcrp030000-asr_E36769-000HealthSupportBusinessReportableSegmentsMember14
Number of employeesCurrentYearInstant_ReportableSegmentsMember157
Number of employeesCurrentYearInstant_CorporateSharedMember79

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 22 of 22 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2023-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass